Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Can maitake MD-fraction aid cancer patients?
Kodama N, Komuta K, Nanba H. Kodama N, et al. Among authors: komuta k. Altern Med Rev. 2002 Jun;7(3):236-9. Altern Med Rev. 2002. PMID: 12126464 Review.
A phase II study of cisplatin, vindesine and continuously infused 5-fluorouracil in the treatment of advanced non-small-cell lung cancer. Osaka Lung Cancer Chemotherapy Study Group.
Nakano T, Ikegami H, Nakamura S, Kawase T, Nishikawa H, Yokota S, Yoshida M, Tachibana T, Igarashi T, Komuta K, Higashino K. Nakano T, et al. Among authors: komuta k. Br J Cancer. 1996 May;73(9):1096-100. doi: 10.1038/bjc.1996.211. Br J Cancer. 1996. PMID: 8624270 Free PMC article. Clinical Trial.
Combination chemotherapy with intermittent erlotinib and pemetrexed for pretreated patients with advanced non-small cell lung cancer: a phase I dose-finding study.
Minami S, Kijima T, Takahashi R, Kida H, Nakatani T, Hamaguchi M, Takeuchi Y, Nagatomo I, Yamamoto S, Tachibana I, Komuta K, Kawase I. Minami S, et al. Among authors: komuta k. BMC Cancer. 2012 Jul 18;12:296. doi: 10.1186/1471-2407-12-296. BMC Cancer. 2012. PMID: 22809298 Free PMC article. Clinical Trial.
Gemcitabine and vinorelbine followed by docetaxel in patients with advanced non-small-cell lung cancer: a multi-institutional phase II trial of nonplatinum sequential triplet combination chemotherapy (JMTO LC00-02).
Hosoe S, Komuta K, Shibata K, Harada H, Iwamoto Y, Ohsaki Y, Morioka T, Origasa H, Fukushima M, Furuse K, Kawahara M. Hosoe S, et al. Among authors: komuta k. Br J Cancer. 2003 Feb 10;88(3):342-7. doi: 10.1038/sj.bjc.6600723. Br J Cancer. 2003. PMID: 12569374 Free PMC article. Clinical Trial.
130 results